You searched for Antibody candidate - Page 63 of 69

News and Trends 6 Sep 2022

IRLAB’s partner Ipsen starts mesdopetam clinical studies

…Ipsen for the development and commercialization of mesdopetam. IRLAB has generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its…

September 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Apr 2023

Ginkgo Bioworks boosts gene therapy capacity with StrideBio asset acquisition

…types, and potentially to improve the safety profile of their future gene therapies. Ginkgo Bioworks is also receiving StrideBio’s existing library of capsids, which includes advanced candidates extensively tested in…

April 5, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 12 Jul 2022

First patient receives new immunotherapy drug for HIV in clinical trial

…a new class of bispecific protein immunotherapy being developed for the treatment of patients with HIV. IMC-M113V is the second candidate in development using Immunocore’s immune‐mobilising monoclonal T cell receptors…

July 12, 2022 - 3 minutesmins - By Liza Laws

News and Trends 22 Feb 2017

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

…when it licensed its lead candidate, ORY-1001, to Roche. The company’s pipeline candidates target lysine-specific demethylase 1 (LSD1), a histone modifying enzyme that regulates the expression of genes involved in…

February 22, 2017 - 5 minutesmins - By External Contributor

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

…struck gold with its fusion peptide, LEVI-04 (p75NTR-Fc). The drug combines the constant region of the IgG antibody with the neurotrophin receptor, p75. The candidate is able to bind each…

February 26, 2018 - 9 minutesmins - By Alex Dale

News and Trends 8 Jan 2018

Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells

…treatment of dermatological problems, including cutaneous warts caused by human papillomavirus. It lead candidate, CyPep-H1, uses a new mechanism of action to specifically target and destroy cells infected by the…

January 8, 2018 - 3 minutesmins - By Alex Dale

News and Trends 1 Feb 2017

Stem Cell Therapy for Sepsis in Pneumonia advances to Phase II

TiGenix has treated the first patient in a new early-stage clinical trial to test its candidate Cx611 as a treatment for sepsis in patients with pneumonia. TiGenix, based in Belgium,…

February 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

…candidate is already in phase II clinical trials for the treatment of solid tumors. In contrast to Ona’s project, which focuses on fat metabolism, Vigeo’s candidate causes cells to produce…

June 17, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 29 Jun 2017

New Drug for Neuropathic Pain Is Forging its Way through the Clinic

…to move its compound towards the next stage of clinical development. The peptide candidate was shown to be safe and well-tolerated and inhibited both of its target enzymes, aminopeptidase N…

June 29, 2017 - 3 minutesmins - By Melanie De Almeida

In Depth 4 Jan 2021

What Does the Next Decade Have in Store for European Biotech?

…identify drug candidates against a specific target. This can significantly reduce the time it takes to select a drug candidate to start clinical testing. A recent example is that of…

January 4, 2021 - 9 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 28 Mar 2018

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson’s disease. BenevolentAI, Europe’s largest private AI company, is…

March 28, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Dec 2022

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

…compliance for clinical trials and late-stage product candidates,” said Kai Pohlmeyer, managing director of Richter-Helm BioLogics. Manufacturing is a strategic focus area for Nykode and its license partners. Under the…

December 19, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

IRLAB’s partner Ipsen starts mesdopetam clinical studies

Ginkgo Bioworks boosts gene therapy capacity with StrideBio asset acquisition

First patient receives new immunotherapy drug for HIV in clinical trial

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

Bang and the Wart is Gone! Norwegian Peptide Destroys HPV-Infected Cells

Stem Cell Therapy for Sepsis in Pneumonia advances to Phase II

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

New Drug for Neuropathic Pain Is Forging its Way through the Clinic

What Does the Next Decade Have in Store for European Biotech?

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!